Stock Market Reviews

SLP (Simulations Plus, Inc.) News

Get the latest news, insights, and market updates on SLP (Simulations Plus, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Simulations Plus AGM: Shareholders Approve All Proposals, Back Annual Say-on-Pay Votes
  Simulations Plus (NASDAQ:SLP) held its annual meeting of shareholders in a virtual format, with CEO Shawn O’Connor chairing the proceedings and CFO and Corporate Secretary Will Frederick presenting the formal business items and preliminary voting results. Virtual meeting format and shareholder part
  Feb 15, 2026 - $SLP
• Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations
  RESEARCH TRIANGLE PARK, N.C., February 09, 2026--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the extension of two separate research collaborations with the U.S. Food and Drug Administration (FDA) and the National Institute of Environmental Health Sciences (NIEHS). The extended projects support ongoing federal research efforts focused on the dev
  Feb 9, 2026 - $SLP
• Simulations Plus to Participate in Upcoming Investor Conferences
  RESEARCH TRIANGLE PARK, N.C., February 03, 2026--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus", "SLP"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that Shawn O’Connor, Chief Executive Officer, will be participating in the upcoming investor conferences:
  Feb 3, 2026 - $SLP
• Seagate's Q2 Earnings Top, Revenues Soar Y/Y on AI-Led Storage Demand
  STX tops fiscal Q2 2026 earnings and revenue, sees strong data center demand, record margins and upbeat fiscal Q3 outlook as nearline capacity ramps.
  Jan 28, 2026 - $SLP
• Be Wary Of SLP Resources Berhad (KLSE:SLP) And Its Returns On Capital
  Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...
  Jan 26, 2026 - $SLP
• Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day
  RESEARCH TRIANGLE PARK, N.C., January 21, 2026--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today hosted its 2026 Virtual Investor Day, outlining how the Company is advancing an integrated, AI-enabled platform to support the evolving needs of the drug development industry and its regulators.
  Jan 21, 2026 - $SLP
• Estimating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)
  Key Insights Simulations Plus' estimated fair value is US$22.01 based on 2 Stage Free Cash Flow to Equity With US$20.33...
  Jan 20, 2026 - $SLP
• SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales
  Simulations Plus Q1 fiscal 2026 EPS miss as software revenue fall 17%, but services momentum and strong bookings support confidence for the rest of fiscal 2026.
  Jan 9, 2026 - $SLP
• Simulations Plus Inc (SLP) Q1 2026 Earnings Call Highlights: Navigating Revenue Challenges with ...
  Despite a dip in total revenue, Simulations Plus Inc (SLP) showcases resilience with robust services performance and strategic advancements in AI integration.
  Jan 9, 2026 - $SLP
• Simulations Plus Q1 Earnings Call Highlights
  Simulations Plus (NASDAQ:SLP) reported fiscal first-quarter 2026 results that management said came in line with internal expectations, as strength in services offset a year-over-year decline in software revenue. On the company’s earnings call, executives also pointed to what they described as improv
  Jan 8, 2026 - $SLP